Session » Rheumatoid Arthritis - Clinical Aspects (ACR): Impact of Various Interventions and Therapeutic Approaches
-
Abstract Number: 2365
Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Rheumatoid Arthritis Therapy with Etanercept
-
Abstract Number: 2366
Effectiveness, Tolerability, and Safety of Subcutaneous Methotrexate in Early Rheumatoid Arthritis: Clinical Data from the St. Gallen Cohort
-
Abstract Number: 2367
Physician Awareness of Suboptimal Patient Adherence to MTX: Results from a Large U.S. Rheumatoid Arthritis Registry
-
Abstract Number: 2368
Impact of Physicians’ Adherence to Treat-to-Target Strategy on Outcomes in Early Rheumatoid Arthritis
-
Abstract Number: 2369
Management of Perioperative Tumor Necrosis -á Inhibitors in Rheumatoid Arthritis Undergoing Arthroplasty: A Systematic Review and Meta-Analysis
-
Abstract Number: 2370
Management of Perioperative Tumor Necrosis Factor α Inhibitors in Rheumatoid Arthritis Undergoing Arthroplasty: A Systematic Review and Meta-Analysis
-
Abstract Number: 2371
Efficacy of First Line Biological Monotherapy in RA: Data from the Czech Registry Attra
-
Abstract Number: 2372
Fatigue and Related Factors in Patients with Rheumatoid Arthritis Treated with Tocilizumab in Daily Clinical Setting
-
Abstract Number: 2373
Compliance in the Rheumatoid Arthritis Comparison of Active Therapies Trial: Triple Vs Etanercept
-
Abstract Number: 2374
Use of Hydroxychloroquine Associated with Improved Lipid Profile in Rheumatoid Arthritis Patients
-
Abstract Number: 2375
Should Physician Reduce patients’ Glucocorticoids to Offset the Risk of Serious Infection Event Among RA Patients Who Switched from Non-Biologic Dmards and Glucocorticoid to Biologics?
-
Abstract Number: 2376
Safety of Rapid Rituximab Infusion in Rheumatoid Arthritis in a Single Community Practice
-
Abstract Number: 2377
A Pilot Randomized Controlled Trial of a Tailored Smoking Cessation Intervention for Rheumatoid Arthritis Patients
-
Abstract Number: 2378
Ethnic Minorities with Rheumatoid Arthritis Achieve a Meaningful Clinical Response at 12 Months Despite Infrequent Use of Biologic Therapies
-
Abstract Number: 2379
Minimal Radiographic Progression in RA Patients Receiving Routine Care in the Espoir Early Arthritis Cohort: Similar Prognosis According to 6 Different Remission Criteria
-
Abstract Number: 2380
Durability of First Biologic Is Not Influenced By Initial/Early DAS28
-
Abstract Number: 2381
Adherence to a Treat-to-Target (T2T) Strategy in Early Rheumatoid Arthritis. Is It Feasible in Daily Clinical Practice?
-
Abstract Number: 2382
Adherence to Dmards in the First Six Months of Treatment in Early Arthritis Patients; Comparing Three Adherence Measures
-
Abstract Number: 2383
The 12-Years Retention Rate of the First-Line TNF-Inhibitor in the Treatment of Rheumatoid Arthritis: Real-Life Data from a Local Registry
-
Abstract Number: 2384
Factors Associated with Methotrexate Treatment Duration, Including Subcutaneous Use, in Patients with Rheumatoid Arthritis: Observations from the VA Database
-
Abstract Number: 2385
Reasons for Non-Vaccination in Rheumatoid Arthritis and Spondyloarthritis Patients
-
Abstract Number: 2386
Patients’ Interpretations of Rheumatoid Arthritis Model Disease States in a Safety-Net Rheumatology Clinic
-
Abstract Number: 2387
Relation Between Disease Activity Indices and Their Individual Components and Radiographic Progression in Rheumatoid Arthritis: A Systematic Literature Review
-
Abstract Number: 2388
DMARD Use after an Initial Acute MI Is Associated with Reduced Risk of a Recurrent Event and Mortality
-
Abstract Number: 2389
MRI Osteitis at Baseline Predicts the Development of Rapid Radiographic Progression at 1 Year Toward Patients with Early-Stage Rheumatoid Arthritis
-
Abstract Number: 2390
Determinants and Impact of Early Initiation of Disease-Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis
-
Abstract Number: 2391
Sustained Rheumatoid Arthritis Remission and Low Disease Activity: Analysis of 13 Years of Follow up in Clinical Practice
-
Abstract Number: 2393
Similar Improvements in Physical Function, Quality of Life and Work Productivity Among Rheumatoid Arthritis Patients Treated with 2 Different Doses of Methotrexate in Combination with Adalimumab
-
Abstract Number: 2394
Sustained Remission Improves Physical Function in RA Patients Treated with Tumor Necrosis Factor Inhibitor
-
Abstract Number: 2395
Understanding Patient Preferences Associated with the Use of Therapies for Rheumatoid Arthritis: Results of a Conjoint Analysis
-
Abstract Number: 2396
Treat to Target in Routine Clinical Practice
-
Abstract Number: 2397
Improvement of Fatigue in Patients with Rheumatoid Arthritis Treated with Biologics: Relationship with Sleep Disorders, Depression and Clinical Efficacy. a Prospective, Multicenter Study
-
Abstract Number: 2398
Continued Participation in a 10-Year Tight Control Treat-to-Target Study in Rheumatoid Arthritis: Why Keep Patients Doing Their BeSt?
-
Abstract Number: 2399
Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey
-
Abstract Number: 2400
Comparing a Tapering Strategy to the Standard Dosing Regimen of TNF Inhibitors in Patients with Rheumatoid Arthritis in Remission or with Low Disease Activity
-
Abstract Number: 2401
Interrupted and Delayed Care in First Nation Patients with Rheumatoid Arthritis: The Best Target for Therapy?
-
Abstract Number: 2402
Evaluation of Perceived Self-Efficacy, Learned Helplessness and Functional Capacity in Patients with Rheumatoid Arthritis
-
Abstract Number: 2404
RA Patients with Inadequate Response to Oral MTX Maintain Satisfactory Disease Control and Durable Long-Term Response When Switched to SC MTX Monotherapy
-
Abstract Number: 2405
Quality of Patient- Clinician Communication in a Diverse Cohort of Adults with Rheumatoid Arthritis
-
Abstract Number: 2406
Primary Non-Adherence, Associated Clinical Outcomes and Healthcare Resource Utilization Among Rheumatoid Arthritis Patients Prescribed Injectable Biologics
-
Abstract Number: 2407
Early Treatment in Rheumatoid Arthritis and Its Effect on Patient Outcomes
-
Abstract Number: 2408
Frequency of Rheumatoid Arthritis Flares in Clinical Practice: Analysis of a Monocentric Cohort of Patients in Stable Remission or Low Disease Activity
-
Abstract Number: 2409
Omega-3 Fatty Acids and Mediterranean Diet As Complimentary Therapies for Rheumatoid Arthritis
-
Abstract Number: 2410
Working Status and Improvements in Work Productivity over Time in an Early Rheumatoid Arthritis (ERA) Cohort
-
Abstract Number: 2411
Assessing Treatment Durability of Infliximab in the Management of Psoriatic Arthritis and Rheumatoid Arthritis Patients in a Canadian Setting
-
Abstract Number: 2412
Regime of Use of Rituximab in Patients with Rheumatoid Arthritis in Daily Clinical Practice
-
Abstract Number: 2413
Similar Response Rates to Anti-Tumor Necrosis Factor and Non- Anti-Tumor Necrosis Factor Biologic Therapies in Ethnic Minority Patients at 6 Months
-
Abstract Number: 2414
Etanercept in Mono Therapy or in Combination with MTX: Results from a Sub Analysis of a German Non-Interventional Study
-
Abstract Number: 2415
Characteristics of Rheumatoid Arthritis Patients Not Receiving Early Initiation of Disease Modifying Therapy
-
Abstract Number: 2416
Do Patterns of Joint Swelling or Tenderness in Rheumatoid Arthritis Patients Impact Disease Activity Outcomes and Pain? Implications for Clinical Practice
-
Abstract Number: 2417
Is Remission Really Achievable in EARLY Rheumatoid Arthritis?
-
Abstract Number: 2418
Treatment Pattern and Direct Cost of Biologics for Rheumatoid Arthritis Patients: A Real-World Analysis of Nationwide Japanese Claims Data
-
Abstract Number: 2419
Efficacy of Biologic Medications in Active Rheumatoid Arthritis: A Systematic Review
-
Abstract Number: 2420
Quality Assessment of Controlled Trials Evaluating Chinese Herbal Medicine in Patients with Rheumatoid Arthritis: a Systematic Review
-
Abstract Number: 2421
Patient Treatment Goals in Rheumatoid Arthritis: Results of Focus Groups Among Rheumatologists, English and Spanish-Speaking Patients
-
Abstract Number: 2423
Prevalence of Subclinical Synovitis Detected By Ultrasound in Rheumatoid Arthritis and Psoriatic Arthritis Patients Receiving Anti-TNF-α Therapy with Extended Interval of Administration
-
Abstract Number: 2424
Comparison of Medication Use in Rheumatoid Arthritis Patients Between University and Private Settings – Results from Ontario Best Practice Research Initiative
-
Abstract Number: 2425
Rheumatoid Arthritis Stable Follow up Visits – 3 Month Versus 6 Month Intervals
-
Abstract Number: 2426
Comparison of Patient Self-Reported and Physician Reported Rheumatoid Arthritis Medication Use – Results from the Ontario Best Practices Research Initiative
-
Abstract Number: 2428
Comparative Study of Rheumatoid Arthritis Disease Activity Indices in Two Populations of Meteor Database
-
Abstract Number: 2429
Seasonal Changes May Influence Activity of Rheumatoid Arthritis